Skip to main content

Publisher: Wiley-Blackwell on behalf of the International Society on Thrombosis and Haemostasis

Volume 3, Number 3, March 2005

Free Content Uncertain times for research on hemophilia and allied disorders
pp. 423-423(1)
Authors: MANNUCCI, P. M.; ROBERTS, H. R.

Favourites:
ADD

Free Content Coley's toxin revisited: immunotherapy or plasminogen activator therapy of cancer?
pp. 424-427(4)
Authors: ZACHARSKI, L. R.; SUKHATME, V. P.

Favourites:
ADD
Favourites:
ADD
Favourites:
ADD

Free Content First experience with direct, selective factor Xa inhibition in patients with non-ST-elevation acute coronary syndromes: results of the XaNADU-ACS Trial
pp. 439-447(9)
Authors: ALEXANDER, J. H.; YANG, H.; BECKER, R. C.; KODAMA, K.; GOODMAN, S.; DYKE, C. K.; KLEIMAN, N. S.; HOCHMAN, J. S.; BERGER, P. B.; COHEN, E. A.; LINCOFF, A. M.; BURTON, J. R.; BOVILL, E. G.; KAWAI, C.; ARMSTRONG, P. W.; HARRINGTON, R. A.

Favourites:
ADD

Free Content One more way that mice and men are different
pp. 448-449(2)
Author: HOFFMAN, M.

Favourites:
ADD

Free Content Megakaryocytes endocytose and subsequently modify human factor V in vivo to form the entire pool of a unique platelet-derived cofactor
pp. 450-456(7)
Authors: GOULD, W. R.; SIMIONI, P.; SILVEIRA, J. R.; TORMENE, D.; KALAFATIS, M.; TRACY, P. B.

Favourites:
ADD

Free Content Asymptomatic thrombophilia—a family affair
pp. 457-458(2)
Authors: SPENCER, F. A.; GOLDBERG, R. J.

Favourites:
ADD

Free Content Risk of a first venous thrombotic event in carriers of a familial thrombophilic defect. The European Prospective Cohort on Thrombophilia (EPCOT)
pp. 459-464(6)
Authors: VOSSEN, C. Y.; CONARD, J.; FONTCUBERTA, J.; MAKRIS, M.; VAN DER MEER, F. J. M.; PABINGER, I.; PALARETI, G.; PRESTON, F. E.; SCHARRER, I.; SOUTO, J. C.; SVENSSON, P.; WALKER, I. D.; ROSENDAAL, F. R.

Favourites:
ADD

Free Content Vessel wall apoptosis and atherosclerotic plaque instability
pp. 465-472(8)
Authors: KAVURMA, M. M.; BHINDI, R.; LOWE, H. C.; CHESTERMAN, C.; KHACHIGIAN, L. M.

Favourites:
ADD

Free Content Mutations in GPIIIa molecule as a cause for Glanzmann thrombasthenia in Indian patients
pp. 482-488(7)
Authors: NAIR, S.; GHOSH, K.; SHETTY, S.; MOHANTY, D.

Favourites:
ADD
Favourites:
ADD

Free Content Protein Z, protein S levels are lower in patients with thrombophilia and subsequent pregnancy complications
pp. 497-501(5)
Authors: PAIDAS, M. J.; KU, D-H. W.; LEE, M-J.; MANISH, S.; THURSTON, A.; LOCKWOOD, C. J.; ARKEL, Y. S.

Favourites:
ADD

Free Content Thrombophilic risk factors in patients with severe carotid atherosclerosis
pp. 502-507(6)
Authors: MARCUCCI, R.; SOFI, F.; FEDI, S.; LARI, B.; SESTINI, I.; CELLAI, A. P.; PULLI, R.; PRATESI, G.; PRATESI, C.; GENSINI, G. F.; ABBATE, R.

Favourites:
ADD

Free Content The incidence and prognostic significance of elevated cardiac troponins in patients with submassive pulmonary embolism
pp. 508-513(6)
Authors: DOUKETIS, J. D.; LEEUWENKAMP, O.; GROBARA, P.; JOHNSTON, M.; SÖHNE, M.; TEN WOLDE, M.; BÜLLER, H.

Favourites:
ADD

Free Content In vitro and in vivo studies of the novel antithrombotic agent BAY 59-7939—an oral, direct Factor Xa inhibitor
pp. 514-521(8)
Authors: PERZBORN, E.; STRASSBURGER, J.; WILMEN, A.; POHLMANN, J.; ROEHRIG, S.; SCHLEMMER, K-H.; STRAUB, A.

Favourites:
ADD

Free Content Does activated protein C-resistant factor V contribute to thrombin generation in hemophilic plasma?
pp. 522-530(9)
Authors: BOS, M. H. A.; MEIJERMAN, D. W. E.; VAN DER ZWAAN, C.; MERTENS, K.

Favourites:
ADD

Free Content The synthetic pentasaccharide fondaparinux reduces coagulation, inflammation and neutrophil accumulation in kidney ischemia–reperfusion injury
pp. 531-540(10)
Authors: FRANK, R. D.; SCHABBAUER, G.; HOLSCHER, T.; SATO, Y.; TENCATI, M.; PAWLINSKI, R.; MACKMAN, N.

Favourites:
ADD

Free Content Endocytosis of plasma-derived factor V by megakaryocytes occurs via a clathrin-dependent, specific membrane binding event
pp. 541-551(11)
Authors: BOUCHARD, B. A.; WILLIAMS, J. L.; MEISLER, N. T.; LONG, M. W.; TRACY, P. B.

Favourites:
ADD

Free Content The von Willebrand factor self-association is modulated by a multiple domain interaction
pp. 552-561(10)
Authors: ULRICHTS, H.; VANHOORELBEKE, K.; GIRMA, J. P.; LENTING, P. J.; VAUTERIN, S.; DECKMYN, H.

Favourites:
ADD
Favourites:
ADD

Free Content Laboratory monitoring of low-molecular-weight heparin therapy—part II
pp. 571-573(3)
Authors: HEMKER, H. C.; AL DIERI, R.; BÉGUIN, S.

Favourites:
ADD
Favourites:
ADD
Favourites:
ADD
Favourites:
ADD

Free Content Hypercoagulability preceding cancer
pp. 577-580(4)
Authors: NIERODZIK, M.; KARPATKIN, S.

Favourites:
ADD

Free Content Hypercoagulability preceding cancer
pp. 580-581(2)
Author: SACKS, P. G.

Favourites:
ADD

Free Content Hypercoagulability preceding cancer
pp. 581-583(3)
Author: SCHULMAN, S.

Favourites:
ADD

Free Content Hypercoagulability preceding cancer
pp. 583-584(2)
Authors: TOFT SØRENSEN, HENRIK; BARON, JOHN A.

Favourites:
ADD

Free Content Hypercoagulability preceding cancer
pp. 585-588(4)
Author: ZACHARSKI, L. R.

Favourites:
ADD

Free Content Mechanisms for acquired activated protein C resistance in cancer patients
pp. 589-590(2)
Authors: SARIG, G.; MICHAELI, Y.; LANIR, N.; BRENNER, B.; HAIM, N.

Favourites:
ADD
Favourites:
ADD
Favourites:
ADD

Free Content Treatment of patients with acquired inhibitors
pp. 595-597(3)
Authors: SALLAH, S.; ALEDORT, L.

Favourites:
ADD

Free Content The 46C→T polymorphism in the factor XII gene (F12) and the risk of venous thrombosis
pp. 597-599(3)
Authors: BERTINA, R. M.; POORT, S. R.; VOS, H. L.; ROSENDAAL, F. R.

Favourites:
ADD

Free Content Should we screen Eastern Mediterranean sickle beta-thalassemia patients for inherited thrombophilia?
pp. 599-600(2)
Authors: OTROCK, Z. K.; MAHFOUZ, R. A. R.; TAHER, A. T.

Favourites:
ADD

Free Content A novel fibrinogen γ chain mutation (γ 239 Gln→His) is the cause of dysfibrinogenemia Vicenza
pp. 600-601(2)
Authors: CASTAMAN, G.; GHIOTTO, R.; DUGA, S.; RODEGHIERO, F.

Favourites:
ADD

Free Content Macrothrombocytopenia in velocardiofacial syndrome
pp. 601-603(3)
Authors: PALLOTTA, R.; EVANGELISTA, V.; MARGAGLIONE, M.; BUCCI, I.; SAPONARI, A.

Favourites:
ADD
Favourites:
ADD

Free Content More on: measuring circulating cell-derived microparticles
pp. 613-614(2)
Authors: FREYSSINET, J-M.; DIGNAT-GEORGE, F.

Favourites:
ADD

Free Content More on: fluvastatin inhibits upregulation of tissue factor expression by antiphospholipid antibodies on endothelial cells
pp. 614-615(2)
Authors: MUSIAL, J.; RYS, D.; BROZEK, J.; SWADZBA, J.; IWANIEC, T.

Favourites:
ADD

Free Content Talking about …
pp. 617-619(3)
Authors: BRUTTOMESSO, G.; MIGLINO, N.

Favourites:
ADD

Free Content Announcements
pp. 620-621(2)

Favourites:
ADD

Free Content Erratum
pp. 622-622(1)

Favourites:
ADD

Free Content Corrigenda
pp. 622-622(1)

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more